Skip to main content

Table 3 Demographics and baseline characteristics by treatment group1.

From: Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial

Clinical data

Control group

Experimental group

pvalue

Gender (male/female)

9/3

9/2

1.0a

Age, years

58.5 (19.2)

53.3 (15.2)

.42b

Most common clinical form (%)

LL# (92%)

LL# (73%)

.31a

Years since leprosy diagnostic

38.4 (16.0)

39.1 (15.7)

.91b

Years free of M. leprae

14.2 (5.6)

14.3 (3.9)

.97b

Ulcers duration (months)

71.7 (82.2)

123.3 (159.6)

.28b

Ulcers area

5.3 (9.2)

4.2 (5.9)

.70b

Ulcers depth

6.3 (5.4)

6.2 (5.1)

.96b

PUSH score

9.7 (3.4)

9.6 (3.3)

.96c

Adapted footwear usage

5 subjects

4 subjects

1.0a

  1. 1Values are means (SDs) unless otherwise indicated. # LL = Lepromatous leprosy.
  2. a As determined by Fisher's exact test.
  3. bAs determined by an independent 2-sample t test.
  4. cAs determined by the Mann-Whitney U test.